Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
In this article:
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.
Advertisement